Related Experiment Video
Updated: Jun 12, 2026

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Letrozole induces hepatotoxicity without causing oxidative stress: the protective effect of melatonin
Mehmet Aydin1, Süleyman Oktar, Orhan Veli Ozkan
1Medical Faculty of Mustafa Kemal University, Department of Physiology, Hatay, Turkey.
Aim:
The aim of this study was to determine the effects of letrozole (LTZ), an aromatase inhibitor (AI), and melatonin (MLT) on hepatic function and oxidative stress in female rats.
Material And Methods:
A total of 32 female rats were divided equally into four groups (n = 8). Control group received saline (0.5 ml/day, oral gavage). LTZ was administered to rats by daily oral gavage at 1 mg/kg dose. LTZ + MLT group was given LTZ (1 mg/kg, oral gavage) plus MLT (0.5 mg/kg/day, s.c.). MLT group was given MLT (0.5 mg/kg/day) by s.c. injection. The activities of superoxide dismutase (SOD) and catalase (CAT) and malondialdehyde (MDA) levels were measured in liver tissue. Total antioxidant capacity (TAC), total oxidant status (TOS), ALT, AST, GGT, ALP, LDH, bilirubin, BUN, creatinine, total cholesterol (TC), high-density lipoprotein (HDL) and triglyceride (TG) were assayed in serum samples.
Results:
The oxidative stress parameters did not differ between groups. LTZ administration increased hepatic function parameters such as AST, LDH, ALP, bilirubin and MLT improved the disturbances of hepatic function. LTZ caused minimal histological changes in liver tissue and MLT treatment reversed those dejenerations.
Discussion:
LTZ may cause hepatotoxicity without inducing oxidative stress and MLT restores hepatic activity.
Insights
Letrozole (LTZ) may harm liver function without increasing oxidative stress, but melatonin (MLT) can restore liver health. This study in female rats shows MLT
Area of Science:
- Pharmacology
- Hepatology
- Toxicology
Background:
- Aromatase inhibitors (AIs) like letrozole (LTZ) are used in cancer therapy.
- Potential side effects of LTZ on hepatic function and oxidative stress are not fully understood.
- Melatonin (MLT), a known antioxidant, may offer protective effects.
Purpose of the Study:
- To investigate the impact of LTZ and MLT on hepatic function in female rats.
- To assess the effects of LTZ and MLT on oxidative stress markers in liver tissue and serum.
Main Methods:
- Thirty-two female rats were divided into four groups: control, LTZ, LTZ + MLT, and MLT.
- LTZ was administered orally (1 mg/kg/day), and MLT was given subcutaneously (0.5 mg/kg/day).
- Hepatic function markers, oxidative stress parameters (SOD, CAT, MDA), and biochemical profiles were analyzed.
Main Results:
- LTZ administration elevated liver enzymes (AST, LDH, ALP), bilirubin, and caused minor histological damage.
- Oxidative stress parameters (SOD, CAT, MDA, TAC, TOS) did not significantly differ between groups.
- MLT treatment ameliorated LTZ-induced hepatic function disturbances and reversed histological changes.
Conclusions:
- Letrozole may induce hepatotoxicity through mechanisms independent of oxidative stress.
- Melatonin demonstrates a protective role, restoring hepatic function and mitigating LTZ-induced liver damage.
- MLT may be a potential therapeutic agent to counteract LTZ-related hepatotoxicity.
More Related Videos
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
10:00Induction and Analysis of Oxidative Stress in Sleeping Beauty Transposon-Transfected Human Retinal Pigment Epithelial Cells
Published on: December 11, 2020
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Teratogenicity
Management of Insomnia
Bioactivation and Tissue Toxicity
Drug Toxicity: Dose-Dependent Reactions